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ABSTRACT
Painful menstruation, premenstrual syndrome and metrorrhagia iuvenilis are one of the most common problems related 
to the sexual cycle in adolescent girls.
Metrorrhagia iuvenilis is acyclic bleeding that occurs in adolescents and lasts from over 10 days even up to 3 months. These 
bleeds are very abundant and have a tendency to relapse. They cause anemia, and severe cases can be life-threatening. 
Premenstrual Syndrome (PMS) is a cluster of somatic, emotional and behavioural symptoms occurring in the luteal phase 
of the menstrual cycle. The aetiology of PMS remains unknown. According to strict diagnostic criteria, an estimated 2.5–5% 
of girls and women are affected by PMS. However, some researchers maintain that the symptoms of PMS may be prevalent 
in as many as 40–80% of girls and women.
This article it has been discussed premenstrual syndrome and metrorrhagia iuvenilis and aspects related to dietotherapy 
were included.
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INTRODUCTION
Premenstrual syndrome and metrorrhagia iuvenilis 
are frequent problems in adolescent gynecology. In the 
prevention and treatment of both disease entities, it is very 
important to include diet therapy as a minimally invasive 
method, which is very important in developmental age. 
Metrorrhagia iuvenilis
Metrorrhagia iuvenilis (heavy menstrual bleeds) is acyclic 
bleeding that occurs in adolescents and lasts over 10 days, 
even up to 3 months. These bleeds are very abundant and 
have a tendency to relapse. They cause anemia, and severe 
cases can be life-threatening [1–6].
In 2009, at the FIGO congress, the so-called criteria were 
set. normal menstruation: the frequency of menstruation 
(from 24 to 38 days), the regularity of menstruation over a pe-
riod of more than 12 months, the duration of bleeding (from 
4.5 to 8.0 days), the volume of blood loss (from 5 mL to 80 mL).
During normal menstruation 90% of wasted blood is in 
the first three days, and the bleeding in the first two days is 
the most abundant. Bleeding that does not meet the above 
conditions is treated as abnormal uterine bleeding (AUB) [7].
Heavy menstrual bleeding (HMB) (above 80 mL) of a cyclic 
nature concerns women most often in the premeonopausal 
age. The clinical definition set by The National Institute for 
Health and Care Excellence (NICE) in 2007 is more practical. 
Defines HMB as excessive loss of menstrual blood, interfering 
with and interfering with the physical, emotional, social 
and material quality of a woman’s life, which can also be 
combined with other symptoms. Prevalence according to 
different authors, it is in the range of 4–9% .
Heavy and prolonged menstrual bleeding (HPMB) 
is abundant and prolonged menstrual bleeding above 80 mL 
and lasting more than 8 days, while intermenstrual bleed-
ing (IMB) this is intermenstrual bleeding. Postmenopausal 
bleeding (PMB) defines postmenopausal bleeding. It is 
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possible to use the term amenorrhea (absent menstrual 
bleeding [AMB]) in the absence of menstrual bleeding over 
a period of more than 90 days.
The causes of abnormal bleeding from the genital 
tract (eg. from the vagina) can be divided into two groups: 
structural and non-structural. The structural reasons 
include: changes in the cervix (eg erosions of the vaginal 
part of the cervix, cervical cancer, polyps of the cervix), 
changes in the endometrium (endometrial hyperplasia, 
uterine polyps, fibroids, adenomyosis, stem cancer). Non-
structural causes include: ovulation disorders/lack of 
ovulation (eg progesterone deficiency, estrogen deficiency, 
inhibin deficiency, PCOS, hyperprolactinemia), thyroid 
disease (hypothyroidism), adrenal diseases (Cushing’s 
disease), haematological diseases (eg coagulopathy, 
thrombocytopenia), diseases of other organs (eg ovarian, 
adrenal or pituitary tumors, cirrhosis of the liver, some 
kidney diseases). Other causes include: obesity, injuries, 
foreign body, stress, medicines used (e.g., antiepileptic, anti-
depressant, anticoagulants, NSAIDs, hormones).
In 2009, the FIGO committee recommended the 
introduction of a new classification of abnormal bleeding 
from the uterus — The PALM-COEIN Classification System. 
The name is an acronym from the first letters of causes that 
can cause bleeding from the uterine cavity:
P — polyp;
A — adenomyosis;
L — fibroids of the uterus;
M — endometrial cancer and proliferation;
C — coagulopathies;
O — ovulation disorders;
E — other causes of disorders;
I — iatrogenic (IUD insert, steroid hormones, anticoagulants, 
antidepressants);
N — not yet classified [7].
Juvenile bleeding usually occurs shortly after menarche, 
when the cycles are anovulatory. Juvenile bleeding is func-
tional uterine bleeding and rarely disappears spontaneously. 
It is assumed that irregular bleeding from the genital tracts in 
pre-pubescent girls up to 2–3 years from menarche may oc-
cur as a physiological phenomenon. Situations with profuse 
bleeding and secondary anemia are dangerous and require 
treatment [8 –15]. When the cycles are anovulatory, bleed-
ing is not cyclical, and there are no typical premenstrual 
symptoms associated with premenstrual syndrome, such 
as fluid retention, breast tenderness, abdominal distension. 
Juvenile bleedings usually have a sudden onset without any 
symptoms which predict them [1, 3, 6, 10, 15]. 
As a result of the lack of ovulation, there is a situation 
in which uncyclic (often unexpected) exfoliation of the ex-
panded and thickened mucous membrane of the uterine 
cavity occurs, which stems from the relative hyperestrogen-
ism (deficiency of progesterone, because ovulation does 
not occur). This results in bleeding. Acyclic bleeding may 
also be due to insufficient exfoliation of the endometrium 
(i.e. endometrium). First, there is a slow endometrial hyper-
plasia for up to 3 months, and then slow functional exfo-
liation of the endometrium takes place. The exfoliation of 
the endometrium to its basal layer can last up to a month. 
Estrogens stimulate the endometrium for growth constantly. 
In the etiology of profuse bleeding is involved the abnormal 
process in the endometrium, which controls the supply of 
arachidonic acid for the production of prostaglandins too. 
In women and girls with profuse bleeding, endometrium 
occurs on a much larger scale than in women with normal 
menstruation, and causes the formation of prostaglandins 
series 2, which affect the functions of the blood vessels and 
affects the sensation of pain [5, 11, 15].
In the case of abrupt juvenile hemorrhage, early 
diagnosis is important to avoid complications that threaten 
health and life [2, 4, 9, 15]. A gynecologist decides whether 
the patient’s condition is acute and requires immediate 
hospitalization, or whether it will be possible to monitor 
it in as an outpatient. During a medical interview, 
information about family diseases is important. This 
includes hematological diseases, information about how 
the patient’s development progressed, other diseases, 
the history of menarche, the course of cycles, and the 
period during which abnormal bleedings started and their 
duration. It is important to establish whether the patient 
takes drugs or dietary supplements, and if so, what kind. 
Of particularly importance is information that excludes or 
confirms hematological problems, whether the patient is 
suffering from hemorrhagic diathesis or whether there are 
bleeds from other places [8, 10, 15].
Excessive menstrual bleeding in girls and women with 
bleeding disorders occurs with a frequency of 10 to 100%, 
depending on the particular disorder. In turn, disturbanc-
es of thrombosis are also more frequent among girls and 
women with excessive menstrual bleeding. Research already 
carried out indicates that coagulation disorders occur in 
5–32% of girls and women with heavy menstruation. On the 
basis of the number of tampons and sanitary towels used, 
the amount of lost blood can be estimated, as the use of 
more than 10 sanitary towels or tampons within 24 hours 
can be a sign of bleeding over 30 mL. During the test, the 
basic parameters (blood pressure, heart rate, conjuncti-
val assessment, and petechiae evaluation) are measured. 
In a gynecological examination, it is important to exclude 
possible pregnancy in juveniles and its consequences of this 
(an imminent abortion or an ectopic pregnancy). In view of 
the bleeding and the fact that it is usually their first contact 
with the gynecologist, girls can be reluctant to undergo 
an examination with the use of a speculum. In gynecology 
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of the developmental age, a long narrow speculum is used if 
necessary, which makes it possible to assess the vagina and 
cervix. It is worth noting that bleeding can be the result of 
sexual violence. Moreover, the cause of bleeding may also 
be injuries experienced while practicing sports. During the 
examination, the gynecologist must rule out the tearing of 
the vaginal walls, polyps, foreign bodies, and must check 
whether the bleeding comes from the uterus. A two-handed 
study in girls who have not had a sexual relationship yet 
should be performed via the anus. This may be particularly 
unpleasant and some authors recommend withdrawing 
from this practice. An ultrasound examination is performed 
via the rectum or ultrasound examination is carried out 
through the abdominal walls, and in the case of patients 
who have had a sexual relationship, an ultrasound exami-
nation is performed. Laboratory tests are recommended: 
complete blood count, coagulation system, FSH, LH, estra-
diol, prolactin, thyroid hormones and TSH [1, 5, 9, 10, 15]. 
On the basis of these, the doctor is able to assess the con-
dition of the patient (exclude anemia, thrombocytopenia, 
plasma defects) and the hormonal causes of acyclic bleed-
ing. The results of the tests allow decisions to be made as to 
how to proceed. Bleedings in the case of anovulatory cycles 
do not always involve excessive blood loss: there are no 
changes in peripheral blood morphology, and girls may not 
have additional symptoms at that time. However, patients 
are always advised to lead a healthy lifestyle, a diet rich in 
iron ions, and sometimes its supplementation. Advice from 
a gynecologist, in the absence of patient’s knowledge, also 
has an educational significance [4, 9, 13 –15].
As mentioned above, it is very important to exclude 
hematological causes of excessive menstrual bleeding and 
juvenile bleeding.
VON WILLEBRAND’S DISEASE
Among women with abundant menstruation, the 
incidence of VWD is 5–20%, and among teenagers with 
juvenile bleeding it may be as high as 36% [4]. In girls 
and women, Von Willebrand’s disease (vWD) is often not 
recognized due to the aforementioned lack of pro-health 
education.
Von Willebrand’s disease is the most common heredi-
tary coagulation problem. It is due to deficiency, dysfunc-
tion or lack of von Willebrand factor, which is necessary for 
platelet adhesion in vascular sites, and for the protection 
of factor VIII with pre-proteolysis in the bloodstream. Von 
Willebrand’s disease appears through bleeding within the 
skin and mucous membranes, including uterine bleeding. 
The incidence of vWD in the general population is 0.6–1.3%, 
depending on the prevalence of people in a given region 
with bleeding symptoms, family history and laboratory ab-
normalities [1–5].
HAEMOPHILIA
Haemophilia is the most common severe hereditary 
disorder of coagulation, but as a disease conjugated to the X 
chromosome, it occurs almost exclusively in men and boys, 
while women are carriers of it.
In women who are carriers of haemophilia, clinical 
signs of hemorrhagic diathesis may or may not occur, 
and the symptomology of bleeding varies widely, from 
asymptomatic to severe bleeding [1–5].
THROMBOCYTOPENIA CONDITIONED 
IMMUNOLOGICALLY
Primary immune-mediated thrombocytopenia (immune 
thrombocytopenia, ITP) is an acquired immune disease 
characterized by isolated thrombocytopenia, defined as the 
number of platelets in peripheral blood below 100x109/l 
in the absence of an obvious initiating or primary cause. ITP 
occurs with the frequency of about 1 per 10000 patients, but 
more often among women between their 30s and 60s [10, 11]. 
Depending on the intensity of thrombocytopenia, there is 
a higher risk of abundant periods and other abnormal birth 
canal bleedings.
The treatment of juvenile metrorrhagia (heavy 
menstrual bleeds) depends on their etiology, the patient’s 
contraceptive needs, her individual ability to comply with 
medical recommendations, tolerability of side effects, costs 
and medical interventions. In the case of girls with adolescent 
bleeding, estrogen-progesterone therapy, clotting drugs, 
and iron preparations are individually selected. Sometimes 
these girls require hospital treatment. Oral progestogens 
may also be effective, but the choice of therapy is specific 
to each patient, depending on her age, puberty, ultrasound 
and laboratory tests. The management of patients with and 
without coagulation disorders is similar [8–12,15].
Increased iron loss, caused by e.g. heavy menstruation, 
also requires proper dietary treatment because it threatens 
with anemia and anemia occurring in children and 
adolescents may results in a wide range of serious health 
consequences such as impaired mental development and 
physical growth and reduces school performance and 
work capacity [16, 17]. Adolescent females are particularly 
vulnerable to iron deficiency because of both high iron losses 
during menstruation and insufficient dietary iron intake. 
Based on a study carried out for a representative national 
Polish sample of adolescents, girls were characterized by 
a significantly lower intake of all forms of iron (total iron, 
heme iron, non-heme iron, anmal iron, plant iron) compared 
to male adolescents [18]. The results of Hamułka et al. [19] 
and Mizgier et al. [20] studies confirm that female individuals 
commonly have too low iron intakes, which in Poland is 
confirmed both for pregnant young women and those who 
are not pregnant. 
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Dietary restrictions and a vegetarian diet may also 
lead to limiting the intake of meat and meat products, and 
ultimately lead to lower iron intake [21].
Iron is present in food products in two forms, as heme 
iron, which is found in meat, fish and other animal products, 
and as non-heme iron, which is found in plant as well as 
animal products. Heme iron is highly bioavailable (25–30% 
of this form is absorbed), although it represents a minor 
part of dietary iron. The absorption of non-heme iron is only 
about 1–10% The best sources of the both forms of iron in 
the diet are: offal, dry legume seeds (peas, beans, lentils, 
chickpeas), poultry, fish, eggs, cereal products (oatmeal, 
whole grain bread, whole grain pasta), and some vegetables 
(beets, chard, peas) [20, 22, 23].
Premenstrual Syndrome (PMS)
Premenstrual Syndrome (PMS) is a cluster of somatic, 
emotional and behavioral symptoms occurring in the lu-
teal phase of the menstrual cycle. Many studies have been 
conducted, but the etiology of PMS remains unknown. 
PMS symptoms substantially affect the quality of a woman’s 
life. According to strict diagnostic criteria, an estimated 
2.5–5% of girls and women are affected by PMS. However, 
some researchers maintain that the symptoms of PMS may 
be prevalent in as many as 40–80% of girls and women. Due 
to this considerable discrepancy, it is necessary to make the 
definition of PMS more precise. Patients with PMS experi-
ence mood disturbances together with physical and emo-
tional symptoms, which recur in the luteal phase and disap-
pear in the follicular phase of the menstrual cycle [24, 25].
In the last decade, the methods of PMS treatment 
have undergone significant changes. Although the 
pathophysiology of the syndrome has not been fully 
elucidated, effective treatment is possible for most 
patients. In women with premenstrual syndrome, body 
composition should be assessed and the appropriate diet 
and physical activity should be taken into consideration.
The results of the studies conducted confirm the 
theory of fluid retention in the body as associated with 
the occurrence of PMS. The theory of fluid retention in the 
body, which suggests that estrogens induce an increased 
synthesis of angiotensinogen in the liver, which leads to 
increased production of aldosterone, which directly affects 
the retention of sodium and potassium loss. It was also 
found that in PMS, there is a slight increase in prolactin 
concentration in the second phase of the sexual cycle, 
perhaps due to the impaired synthesis or secretion of 
dopamine and serotonin in the central nervous system. It has 
been proven that dopamine exerts direct neurotransmission 
on the kidneys, and serotonin is responsible for excessive 
sensitivity. The feeling of weight in the lower abdomen and 
pain in the sacral region are a consequence of retention in the 
uterus and venous stasis in the pelvis. Swelling of the central 
nervous system is the cause of headaches, dizziness, nausea, 
mental tension, insomnia, anxiety, depression, and increased 
appetite. At such times, women very often have a craving for 
something sweet. An increase in body weight of 2 to 4 kg 
usually disappears in the first days of menstruation [24–27].
The results of Mizgier et al.’s study seem to confirm 
the fluid retention theory, since statistically significant 
differences were observed in the two study groups for total 
body water (TBW) in kilograms. Higher values were reported 
for PMS women (p < 0.005). This statistical significance was 
confirmed for both the whole study population and for 
women with BMI ≥ 25 kg/m2. Although the pathophysiology 
behind PMS has not been fully explained, it is recommended 
to assess the state of nutrition and body composition which, 
as the current study shows, are related to premenstrual 
syndrome prevalence. Since they are modifiable factors, 
PMS treatment should include a balanced diet and physical 
activity, which will help to modify not only body mass but 
also fat mass. Further studies on PMS women should also 
offer recommendations for lifestyle interventions [24]. 
The results of the study suggest the importance of 
proper eating habits and physical activity on the course 
of menstrual cycles [28]. Physical exertion, e.g. aerobics, but 
also relaxation or relaxation exercises may be beneficial.
It should be added that conventional methods of 
treatment of cyclic pain and discomfort over a time period 
of approximately one mnth, although numerous and di-
verse, have disadvantages, including side effects, disrup-
tions of women’s functioning. Many of these women also 
turn to herbal medicine. Clinical evidence supports the ef-
ficacy of Vitex agnus-castus, but other drugs commonly used 
by western herbalists to treat menstrual symptoms are not 
supported by clinical trials. This raises concerns about the 
effectiveness and safety of these herbs. Treatment options 
for women must be extended and individualized when cur-
rent conventional strategies fail, which requires appropriate 
clinical trials of potentially useful herbal medicines [29].
Some women with PMS want to be treated with acu-
puncture or acupressure. Limited available evidence suggests 
that acupuncture and acupressure may improve both the 
physical and mental symptoms of premenstrual syndrome. 
There was insufficient evidence to determine whether there 
is a difference between groups in the frequency of adverse 
events. There is also no evidence comparing acupuncture 
or acupressure with currently recommended therapies for 
PMS, such as selective serotonin reuptake inhibitors (SSRIs). 
Further research is necessary, using approved measures for 
PMS, appropriate blindness and appropriate comparative 
groups reflecting the best practice currently [30].
The basic elements of the diagnosis are: the need 
to prospectively determine the time of appearance of 
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symptoms and the occurrence of at least 30% increase in 
the severity of symptoms in the luteal phase compared to 
the follicular phase. An additional criterion is the exclusion 
of mental illness and the condition that women did not use 
oral contraception and have regular monthly cycles [26–27].
Any woman who notices the severity of symptoms should 
consult a doctor. It is necessary to exclude other diseases, 
both internal, neurological and gynecological, which may 
give similar ailments. Any ailment that contributes to the 
deterioration of the comfort of life, although it does not 
cause negative medical effects, should be treated. A typical 
premenstrual syndrome should be distinguished from 
monthly complaints, the primary cause of which is not 
stress, anxiety, depression, emotional disorders, family or 
professional problems. The study should exclude women 
with dysmenorrhea, in which local ailments occurring only at 
the beginning of bleeding, and persistent during its duration, 
accompanied by abnormalities of the sexual cycle, prevail.
Internal and gynecological examinations are necessary. 
These aim to identify possible organic changes that may 
be responsible for ailments and at the same time may 
have serious health consequences. Similar discomfort is 
often felt by women after gynecological operations, after 
childbirth or abortions, and those suffering from other 
organic diseases of the reproductive organs. In premenstrual 
syndrome, the doctor may not find any palpable lesions in 
the genital organ during a pelvic examination. Sometimes 
the determination of hormonal activity of the ovaries is 
indicated and helpful in further proceedings. The simplest 
method is to measure the basic temperature of the body 
daily, immediately after waking up throughout the menstrual 
cycle. The doctor may also order the a cytohormonic smear 
to be taken from the vagina, a cervical mucus crystallization 
test or, in justified cases, determination of the level of sex 
hormones (ovarian and pituitary) in the blood serum. People 
with milder symptoms of premenstrual syndrome may try 
nonpharmacological methods.
If possible, it is good to avoid stress, and more 
difficult tasks should be planned for the first half of the 
cycle. Inhalation of essential oils may be helpful, and it is 
recommended to reduce the consumption of sodium and 
caffeine. Writing a diary and noting the changes in the mood, 
and the ways of reacting and physical ailments can help to 
understand changes in the body and to control behavior. 
Understanding and acceptance on the part of relatives is of 
course very important, and a woman has the right to expect 
various forms of help and tolerance during this period. With 
a higher severity of premenstrual symptoms, especially in 
full-blown PMDD, non-pharmacological methods usually 
fail and should not be used as the sole method of treatment 
for more than 3 months. After this period, pharmacotherapy 
should be considered.
As first-line drugs with proven efficacy, antidepressants 
from the SSRI (serotoninergic) group are currently used. 
It is interesting that studies indicate similar effectiveness of 
these drugs used both continuously and intermittently only 
in the second phase of the cycle. Recently, the latter strategy 
has been preferred. These drugs may cause resolution or 
outstanding relief of most of the symptoms of PMDD. Other 
pharmaceuticals are less effective, act on some symptoms 
or are associated with a higher risk of use. Some efficacy 
of synthetic analogues of hypothalamic gonadotropin-re-
leasing hormone has been demonstrated, but they are not 
routinely recommended. These drugs radically change the 
body’s hormonal status, for example, they can overcome 
ovulation, can have other important side effects, and are also 
expensive. There are several drugs that are useful in some 
cases to alleviate individual syndromes of the syndrome. Al-
prazolam relieves psychical tension, but should be avoided 
due to the possibility of substitution. Only spironolactone is 
recommended for diuretics, and can reduce body swelling, 
while non-steroidal anti-inflammatory drugs, especially for 
pro-zene and mefenamic acid, can be beneficial especially 
when pain is an important symptom of the syndrome.
Breast engorgement and tenderness may be amelio-
rated, through vitamin E administered only in the second 
half of the cycle, and gammalinolenic acid (e.g. in evening 
primrose oil). Some studies have demonstrated the benefit 
of taking calcium carbonate at 1.200 mg per day during 
three monthly cycles. There is no evidence for the effective-
ness of supplementing magnesium, manganese and other 
micronutrients. The validity of the use of contraceptives 
was also not confirmed. Several randomized clinical trials 
were performed in which vitex agnus-castus (monk’s pep-
per) was used to alleviate the symptoms of PMS syndrome. 
The results indicate a significant improvement in the symp-
toms of PMS syndrome in 42% to 77% of women taking 
the drug for 3 months. No side effects were noted. The 
randomized study also compared the effectiveness of Mas-
todynon® with pyridoxine. A better therapeutic effect was 
demonstrated in patients treated with Mastodynon®: in 80% 
of patients a significant improvement in symptom percep-
tion was obtained compared to 21% in the group treated 
with vitamin B6. The effectiveness of vitex agnus-castus 
extract in alleviating emotional disorders in the most severe 
form of PMS, pre-menstrual dysphoric disorder (PMDD) has 
also been confirmed. Vitex agnus-castus showed efficacy 
comparable with fluoxetine, one of the most frequently used 
in PMDD selective serotonin reuptake inhibitors (SSRIs) [27]. 
Mastodynon’s ingredients have been selected so as to 
have the greatest possible extent to alleviate the various 
symptoms observed in PMS [26].
It was also shown that aromatherapy with Citrus aurantium 
flower improved the symptoms of premenstrual tension [31].
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The methods of treatment also include the 
administration of:
 Ū gestagens in the second half of the cycle (17–26 days), 
e.g. didrogesterone (10 mg 1 once 1 tablet) or proges-
terone (50 mg 1 once 1 tablet),
 Ū contraceptives that stop ovulation when contraception 
is indicated,
 Ū prolactin inhibitors, when the dominant symptom is 
mastodynia with abdominal discomfort and edema 
tendency, e.g. bromocriptine (½–1 tablet), from day 
14–28 of the cycle,
 Ū diuretics as a supplement to therapy or exclusive 
treatment, when the dominant symptom is swelling 
and weight gain, e.g. hydrochlorothiazide 12.5–25 mg 
per day,
 Ū a set of vitamins A, B (especially B6), D and E.
Risk factors for the occurrence of PMS symptoms 
may be vitamin and mineral deficiencies. To synthesize 
neurotransmitters potentially involved in the pathogenesis 
of this syndrome, B vitamins and folic acid are needed, 
among others [32]. Increased amounts of thiamine 
(vitamin B1), riboflavin (vitamin B2) and pyridoxine 
(vitamin B6) have a beneficial effect on the alleviation of 
PMS symptoms. Bertone-Johnson et al. [33] emphasize 
the importance of vitamin D, which at a dose of ≥ 2.5 μg 
reduces the risk of premenstrual syndrome. Siuda and 
Rabe-Jabłońska [34] suggest calcium substitution from 
ovulation to menstruation, at a dose of 1200 mg/day, with 
the simultaneous use of tryptophan at a dose of 6 g/day.
In view of the quite diverse positions in the literature 
regarding the supplementation and dosage of vitamins 
and microelements, it is safest to use a balanced diet. In this 
way, overdose is avoided and the effect is reversed to that 
of a therapeutic one. Selecting the correct, balanced diet is 
a task for the dietitian. Based on the nutritional interview, he 
or she has the opportunity to recognize the mistakes made 
and determine the need and scope of diet modification, 
which will contribute to reducing the perceived PMS 
symptoms [32]. 
SUMMARY
Adolescent girls often complain of heavy menstrual 
bleeding, and premenstrual symptoms are also common. 
Differential diagnosis is extensive and requires vigilance, 
especially in the area of coagulation disorders. In establish-
ing the diagnosis, the gynecologist’s cooperation with the 
hematologist may be helpful, which may prove invaluable 
in achieving success.
With reference to the occurrence of above mentioned 
problems, there is a need for nutritional education among 
adolescents. Dietary intervention is the most appropriate 
way to improve knowledge status in young women and 
can act as an alternative to conventional treatment. 
Unfortunately, there are no educational campaigns in Poland 
related to diet therapy possible in prementrual syndrome 
or iron deficiency. Such education should be targeted at 
broadening knowledge by identifying and promoting 
various sources of well-absorbed iron. Such a strategy will 
be beneficial for an individual’s health during adolescence 
and for their future health.
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